HPV 16 E7/HSP70 fused DNA vaccine （Johns Hopkins University）

N/A

Report date: 2022/10/24 17:58:06

Base Information

Drug NameHPV 16 E7/HSP70 fused DNA vaccine （Johns Hopkins University）

Drug Alias NameE7/HSP70

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine

Mechanisms of ActionProtein E7 modulatorsHeat shock 70 kDa protein 1 modulators

TargetsProtein E7Heat shock 70 kDa protein 1

Therapy Area/IndicationsUterine Cervical Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesJohns Hopkins University

China Registration ClassN/A

Develop Information

Active CompaniesSidney Kimmel Comprehensive Cancer Center

Inactive CompaniesN/A

Active IndicationsUterine Cervical Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A